Pfizer tops earnings estimates, hikes full-year guidance as Covid products help sales
Read more at CNBC
-
Pfizer’s earnings crush estimates as company raises guidance
Business - MarketWatch - October 29 -
Lowe's beats on earnings and hikes guidance, but still expects sales to fall this year
Business - CNBC - 3 days ago -
Bristol Myers Squibb tops earnings estimates and hikes outlook, helped by Eliquis and new drugs
Business - CNBC - October 31 -
Biogen’s stock hit by soft sales of Alzheimer’s treatment
Business - MarketWatch - October 30 -
Bristol Myers’s stock pops as earnings top estimates and company raises guidance
Business - MarketWatch - October 31 -
Merck tops earnings estimates on strong demand for Keytruda, new drugs even as HPV vaccine sales fall
Business - CNBC - October 31 -
Merck’s stock slides as Q3 earnings beat estimates, but company lowers guidance
Business - MarketWatch - October 31 -
Comcast tops earnings estimates as Olympics propel the company
Business - CNBC - October 31
More from CNBC
-
Donald Trump chooses hedge fund executive Scott Bessent for Treasury secretary
Business - CNBC - 10 hours ago -
'I have no money': Thousands of Americans see their savings vanish in Synapse fintech crisis
Business - CNBC - 15 hours ago -
Why X's new terms of service are driving some users to leave Elon Musk's platform
Business - CNBC - 18 hours ago -
One of the world's richest families plans to create Paris's next big soccer success
Business - CNBC - 17 hours ago -
Amazon to invest another $4 billion in Anthropic, OpenAI's biggest rival
Business - CNBC - 18 hours ago